DYRK1A型
磷酸化
布鲁顿酪氨酸激酶
化学
酪氨酸激酶
激酶
酪氨酸
蛋白酪氨酸激酶
生物化学
细胞生物学
药理学
生物
信号转导
作者
Thu Lan Nguyen,Corinne Fruit,Yann Hérault,Laurent Meijer,Thierry Besson
标识
DOI:10.1080/13543776.2017.1360285
摘要
INTRODUCTION: Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a eukaryotic serine-threonine protein kinase belonging to the CMGC group. DYRK1A hyperactivity appears to contribute to the development of a number of human malignancies and to cognitive deficits observed in Down syndrome and Alzheimer's disease. As a result, the DYRK1A kinase represents an attractive target for the synthesis and optimization of pharmacological inhibitors of potential therapeutic interest. Like most tyrosine kinase inhibitors developed up to the market, DYRK1A inhibitors are essentially acting by competing with ATP for binding at the catalytic site of the kinase. Areas covered: This paper reviews patent activity associated with the discovery of synthetic novel heterocyclic molecules inhibiting the catalytic activity of DYRK1A. Expert opinion: Despite the important role of DYRK1A in biological processes and the growing interest in the design of new therapeutic drugs, there are only few patented synthetic DYRK1A inhibitors and most of them were and are still developed by academic research groups, sometimes with industrial partners.
科研通智能强力驱动
Strongly Powered by AbleSci AI